Boston Scientific (BSX) Shares Outstanding (Weighted Average) (2016 - 2025)
Boston Scientific (BSX) has disclosed Shares Outstanding (Weighted Average) for 17 consecutive years, with $1.5 billion as the latest value for Q4 2025.
- Quarterly Shares Outstanding (Weighted Average) rose 0.6% to $1.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 billion through Dec 2025, up 0.6% year-over-year, with the annual reading at $1.5 billion for FY2025, 0.6% up from the prior year.
- Shares Outstanding (Weighted Average) hit $1.5 billion in Q4 2025 for Boston Scientific, roughly flat from $1.5 billion in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.5 billion in Q3 2025 to a low of $1.4 billion in Q1 2021.
- Historically, Shares Outstanding (Weighted Average) has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2023.
- Biggest five-year swings in Shares Outstanding (Weighted Average): fell 0.67% in 2021 and later increased 2.27% in 2024.
- Year by year, Shares Outstanding (Weighted Average) stood at $1.4 billion in 2021, then rose by 0.58% to $1.4 billion in 2022, then grew by 1.57% to $1.5 billion in 2023, then grew by 1.27% to $1.5 billion in 2024, then increased by 0.6% to $1.5 billion in 2025.
- Business Quant data shows Shares Outstanding (Weighted Average) for BSX at $1.5 billion in Q4 2025, $1.5 billion in Q3 2025, and $1.5 billion in Q2 2025.